Univariatea | |||
---|---|---|---|
OR | 95% CI | p-value | |
Need factors | |||
Fatigue | 1.24 | 1,09-1,41 | 0.001 |
Polypharmacy | 1.18 | 1,01-1,38 | 0.04 |
Cancer-related factors | |||
Stage | 0.09 | ||
I | ref | ||
II | 2.01 | 0,85-4,78 | 0.11 |
III | 2.67 | 1,02-6,96 | 0.05 |
IV | 5.93 | 1,18-29,68 | 0.03 |
Chemotherapy | 2.21 | 1,17-4,19 | 0.02 |
Radiotherapy | 2.38 | 1,19-4,77 | 0.02 |
Changes in need factors | |||
ADL | 0.01 | ||
persistently independent | ref | ||
became indepedent | 0.93 | 0,27-3,13 | 0.90 |
became dependent | 3.19 | 1,55-6,54 | 0.002 |
persistently dependent | 0.85 | 0,28-2,54 | 0.77 |
IADL | 0.04 | ||
persistently independent | ref | ||
became indepedent | 1.81 | 0,60-5,50 | 0.29 |
became dependent | 2.86 | 1,36-6,04 | 0.01 |
persistently dependent | 2.04 | 0,66-6,33 | 0.22 |
Depression | 0.06 | ||
persistently normal | ref | ||
became normal | 2.53 | 0,77-8,32 | 0.13 |
became depressed | 3.03 | 1,21-7,60 | 0.02 |
persistently depressed | 2.53 | 0,34-18,59 | 0.36 |
Fatigue | 0.003 | ||
persistently normal | ref | ||
became normal | 6.00 | 1,55-23,19 | 0.01 |
became impaired | 4.00 | 1,19-13,42 | 0.03 |
persistently impaired | 8.27 | 2,61-26,22 | < 0,001 |
Polypharmacy | 0.04 | ||
persistently normal | ref | ||
became normal | 2.51 | 0,60-10,52 | 0.21 |
became impaired | 2.72 | 1,15-6,46 | 0.02 |
persistently impaired | 2.93 | 0,93-9,25 | 0.07 |